Eisai’s affiliates in China are wholly-owned by Eisai Co., Ltd. (Eisai), a Japanese multinational pharmaceutical company headquartered in Tokyo, with strong R&D capabilities.
Eisai has been smoothly developing its business in China since the early 1990s, starting with the establishment of Shenyang Eisai Pharmaceutical Co., Ltd. in 1991, followed by the establishment of Eisai Suzhou Pharmaceutical Co., Ltd, and was officially renamed Eisai China.
International Pharma companies
Takeda is a global bio-pharmaceutical company built on traditional values and driven by innovative research. The patient is at the center of everything we do: Takeda is committed to bringing better health and a brighter future to people around the world.
百时美施贵宝是一家以“研发并提供创新药物，帮助患者战胜严重疾病”为使命的全球领先的生物制药公司，始终践行“引领科学，改变患者生命”的企业愿景。
在全球，百时美施贵宝在肿瘤学、血液学、免疫学和心血管疾病领域处于领先地位，并拥有业内最丰富、最具前景的产品管线之一。
在中国，百时美施贵宝致力于成为“根植中国、源于中国”的创新领导者。公司于年进入中国，于同年成立的中美上海施贵宝制药有限公司是中国改革开放以后成立的第一家中美合资制药企业。年来，百时美施贵宝在中国已上市了超过款产品及适应症，涉及肿瘤学、血液学、病毒学及心血管等疾病领域。
如今，百时美施贵宝中国正在成为公司全球研发、制造、商业和创新中心之一。为了惠及更多中国患者，我们将丰富并加快引入百时美施贵宝全球创新产品线，使中国的产品管线与全球一致。同时，作为中国的长期合作伙伴，百时美施贵宝始终致力于与中国政府共同努力，促进药物创新环境并提升中国患者对公司创新药物的可及。
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Haematology, Neuroscience and Gastroenterology. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.
A Hypera Pharma é uma das maiores empresas farmacêuticas do Brasil e está presente em todos os segmentos relevantes do setor. Com posição de liderança em diversas categorias, oferece produtos de alta qualidade e segurança, investindo continuamente em inovação e crescendo de forma sustentável, para que as pessoas vivam mais e melhor.
Empowering You – to feel our passion for SAP
We are a team of innovative and passionate people who specialize in creating value-added SAP solutions and guiding our customers on their journey to becoming intelligent businesses. We focus on SAP Consulting, SAP Development, Managed Cloud Services, Application Management Services & Technology and beyond. More than 16,000 employees in over 30 countries show that diversity is integral to our DNA.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, we create value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, we take a long-term perspective. Around 52,000 employees serve more than 130 markets in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Our purpose is to reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.
Our 240-year-old history and Japanese heritage through everything we do. Takeda has brought hope to people around the world through our people-centered and innovation-driven approach to science and medicine. We Focus on solving unmet needs where we can make a real difference and on putting patients first. Our focus on Rare Diseases, Immunology, Gastroenterology & oncology and soon will launch Vaccines in India.